Growth Metrics

BioLineRx (BLRX) Cash from Investing Activities Growth (1y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -114.28%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 826.39%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -674.01%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -166.24%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -122.45%
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00 -103.02%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -103.02%
Sep 30, 2025 -63.90%
Jun 30, 2025 57.15%
Mar 31, 2025 -149.00%
Dec 31, 2024 154.70%
Sep 30, 2024 148.35%
Jun 30, 2024 -177.88%
Mar 31, 2024 151.23%
Dec 31, 2023 -628.09%
Sep 30, 2023 127.43%
Jun 30, 2023 10.66%
Mar 31, 2023 31.58%
Dec 31, 2022 -3.40%
Sep 30, 2022 -37,437.50%
Jun 30, 2022 267.16%
Mar 31, 2022 113.92%
Dec 31, 2021 -53.20%
Sep 30, 2021 -99.47%
Jun 30, 2021 -7.01%
Mar 31, 2021 -685.71%
Dec 31, 2020 167.72%
Sep 30, 2020 45.37%
Jun 30, 2020 -190.58%
Mar 31, 2020 166.48%
Dec 31, 2019 149.53%
Sep 30, 2019 -0.71%
Jun 30, 2019 130.32%
Mar 31, 2019 -215.20%
Dec 31, 2018 -278.70%
Sep 30, 2018 247.93%
Jun 30, 2018 115.48%
Mar 31, 2018 491.37%
Dec 31, 2017 81.80%
Sep 30, 2017 -213.06%
Jun 30, 2017 -784.82%
Mar 31, 2017 -17.35%
Dec 31, 2016 -36.16%
Sep 30, 2016 475.03%
Jun 30, 2016 -9.33%
Mar 31, 2016 108.00%
Dec 31, 2015 175.59%
Sep 30, 2015 -455.33%
Jun 30, 2015 -22.00%
Mar 31, 2015 -8.47%
Dec 31, 2014 -1,001.61%
Sep 30, 2014 -115.42%
Jun 30, 2014 -41.12%
Mar 31, 2014 -58.69%